Landos Biopharma, Inc. (LABP) Earning

NASDAQ Currency in USD Disclaimer

$22.93

north_east NA Past Year
Day's range
$22.75
Day's range
$22.94

Landos Biopharma, Inc. Analyst EPS Estimates

Quarter Number of Estimates Low Estimate High Estimate Average Estimate
Q1 2024 1 -$0.88 -$0.88 -$0.88
Q2 2024 1 -$0.80 -$0.45 -$0.63
Q3 2024 1 -$0.48 -$0.48 -$0.48
Q4 2024 1 -$0.53 -$0.53 -$0.53
Q1 2025 1 -$0.67 -$0.67 -$0.67
Q2 2025 1 -$0.52 -$0.52 -$0.52
Q3 2025 1 -$0.46 -$0.46 -$0.46
Q4 2025 1 -$0.50 -$0.50 -$0.50

Landos Biopharma, Inc. Earnings Date And Information

Landos Biopharma, Inc. last posted its earnings results on Thursday, May 9th, 2024. The company reported $-1.43 earnings per share for the quarter, missing analysts' consensus estimates of $-1 by $0.43. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Landos Biopharma, Inc. has generated $-4 earnings per share over the last year ($-3.5 diluted earnings per share) and currently has a price-to-earnings ratio of -5.74. Landos Biopharma, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 7th, 2024 based on prior year's report dates.

Landos Biopharma, Inc. Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
05/09/2024 Q1 2024 -$1.00 -$1.43 -0.43 $0 $0
03/21/2024 Q4 2023 -$0.91 -$0.99 -0.08 $0
11/09/2023 Q3 2023 -$0.79 -$0.94 -0.15 $0
08/09/2023 Q2 2023 -$1.10 -$0.63 0.47 $0
05/12/2023 Q1 2023 -$1.00 -$0.86 0.14 $0
03/23/2023 Q4 2022 -$1.50 -$0.96 0.54 $0
11/10/2022 Q3 2022 -$2.90 -$1.98 0.92 $0
08/11/2022 Q2 2022 -$3.70 -$2.81 0.89 $0
05/12/2022 Q1 2022 -$3.70 -$3.67 0.03 $0
03/24/2022 Q4 2021 -$0.33 -$5.20 -4.87 $-18,000,000
11/15/2021 Q3 2021 -$4.40 -$3.20 1.2 $0
07/29/2021 Q2 2021 -$1.40 $1.20 2.6 $18.00 M
05/17/2021 Q1 2021 -$0.37 -$3.80 -3.43 $0
03/31/2021 Q4 2020 -$2.90 $0
09/29/2020 Q3 2020 -$2.52 $0
06/29/2020 Q2 2020 -$1.46 $0
03/30/2020 Q1 2020 -$1.78 $0
12/30/2019 Q4 2019 -$1.08 $0
 

Landos Biopharma, Inc. Earnings: FAQ's

When is Landos Biopharma, Inc.'s earnings date?

Landos Biopharma, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 7th, 2024 based off last year's report dates.

How can I listen to Landos Biopharma, Inc.'s earnings conference call?

The conference call for Landos Biopharma, Inc.'s latest earnings report can be listened to online.

How can I read Landos Biopharma, Inc.'s conference call transcript?

The conference call transcript for Landos Biopharma, Inc.'s latest earnings report can be read online.

How much profit does Landos Biopharma, Inc. generate each year?

Landos Biopharma, Inc. (:LABP) has a recorded net income of $0. Landos Biopharma, Inc. has generated $-3.5 earnings per share over the last four quarters.

What is Landos Biopharma, Inc.'s price-to-earnings ratio?

Landos Biopharma, Inc. (:LABP) has a price-to-earnings ratio of -5.74 and price/earnings-to-growth ratio is 0.34.

Portfolio Sync
Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED